Article Information
History
- January 26, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Falko Tesch1,*,
- Franz Ehm1,
- Annika Vivirito2,
- Danny Wende3,
- Manuel Batram4,
- Friedrich Loser5,
- Simone Menzer6,
- Josephine Jacob2,
- Martin Roessler3,
- Martin Seifert1,
- Barbara Kind1,
- Christina König5,
- Claudia Schulte3,
- Tilo Buschmann7,
- Dagmar Hertle3,
- Pedro Ballesteros3,
- Stefan Baßler7,
- Barbara Bertele5,
- Thomas Bitterer6,
- Cordula Riederer8,
- Franziska Sobik8,
- Lukas Reitzle9,
- Christa Scheidt-Nave9 and
- Jochen Schmitt1
- 1Center for Evidence-Based Healthcare (ZEGV), University Hospital and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany
- 2InGef - Institute for Applied Health Research Berlin, Berlin, Germany
- 3BARMER Institut für Gesundheitssystemforschung (bifg), Berlin, Germany
- 4Vandage GmbH, Bielefeld, Germany and Faculty for Business Administration and Economics, Bielefeld University, Bielefeld, Germany
- 5Techniker Krankenkasse, Hamburg, Germany
- 6IKK classic, Dresden, Germany
- 7AOK PLUS, Dresden, Germany
- 8DAK-Gesundheit, Hamburg, Germany
- 9Robert Koch Institut, Berlin, Germany
- ↵*Corresponding author: Falko Tesch, Center for Evidence-Based Healthcare (ZEGV), University Hospital and Faculty of Medicine Carl Gustav Carus, TU Dresden, Fetscherstr. 74, 01307 Dresden, Germany. email: correspondence.zegv{at}ukdd.de
Posted January 26, 2023.
Incident autoimmune diseases in association with a SARS-CoV-2 infection: A matched cohort study
